230 related articles for article (PubMed ID: 31711377)
21. Interaction between norovirus and Histo-Blood Group Antigens: A key to understanding virus transmission and inactivation through treatments?
Chassaing M; Boudaud N; Belliot G; Estienney M; Majou D; de Rougemont A; Gantzer C
Food Microbiol; 2020 Dec; 92():103594. PubMed ID: 32950136
[TBL] [Abstract][Full Text] [Related]
22. Lewis b antigen is a common ligand for genogroup I norovirus strains.
Someya Y
FEBS Open Bio; 2022 Sep; 12(9):1688-1695. PubMed ID: 35711036
[TBL] [Abstract][Full Text] [Related]
23. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
[TBL] [Abstract][Full Text] [Related]
24. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
Koromyslova AD; Morozov VA; Hefele L; Hansman GS
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
[TBL] [Abstract][Full Text] [Related]
25. Evolution of the interactions between GII.4 noroviruses and histo-blood group antigens: Insights from experimental and computational studies.
Liang Y; Wang WB; Zhang J; Hou JW; Tang F; Zhang XF; Du LF; Su JG; Li QM
PLoS Pathog; 2021 Jul; 17(7):e1009745. PubMed ID: 34252166
[TBL] [Abstract][Full Text] [Related]
26. Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens.
Chen Y; Tan M; Xia M; Hao N; Zhang XC; Huang P; Jiang X; Li X; Rao Z
PLoS Pathog; 2011 Jul; 7(7):e1002152. PubMed ID: 21811409
[TBL] [Abstract][Full Text] [Related]
27. Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.
de Rougemont A; Ruvoen-Clouet N; Simon B; Estienney M; Elie-Caille C; Aho S; Pothier P; Le Pendu J; Boireau W; Belliot G
J Virol; 2011 May; 85(9):4057-70. PubMed ID: 21345963
[TBL] [Abstract][Full Text] [Related]
28. Crystal structures of GI.8 Boxer virus P dimers in complex with HBGAs, a novel evolutionary path selected by the Lewis epitope.
Hao N; Chen Y; Xia M; Tan M; Liu W; Guan X; Jiang X; Li X; Rao Z
Protein Cell; 2015 Feb; 6(2):101-16. PubMed ID: 25547362
[TBL] [Abstract][Full Text] [Related]
29. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses.
Alvarado G; Salmen W; Ettayebi K; Hu L; Sankaran B; Estes MK; Venkataram Prasad BV; Crowe JE
Nat Commun; 2021 Jul; 12(1):4320. PubMed ID: 34262046
[TBL] [Abstract][Full Text] [Related]
30. [Analyses of Binding Profiles of the GII. 12 Norovirus with Human Histo-blood Group Antigens].
Jin M; Chen K; Song J; Li H; Zhang Q; Kong X; Liu N; Duan Z
Bing Du Xue Bao; 2015 Mar; 31(2):164-9. PubMed ID: 26164942
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for norovirus inhibition and fucose mimicry by citrate.
Hansman GS; Shahzad-Ul-Hussan S; McLellan JS; Chuang GY; Georgiev I; Shimoike T; Katayama K; Bewley CA; Kwong PD
J Virol; 2012 Jan; 86(1):284-92. PubMed ID: 22031945
[TBL] [Abstract][Full Text] [Related]
32. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
[TBL] [Abstract][Full Text] [Related]
33. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.
Shanker S; Czakó R; Sapparapu G; Alvarado G; Viskovska M; Sankaran B; Atmar RL; Crowe JE; Estes MK; Prasad BV
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5830-E5837. PubMed ID: 27647885
[TBL] [Abstract][Full Text] [Related]
35. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
[TBL] [Abstract][Full Text] [Related]
36. Structural Basis for Human Norovirus Capsid Binding to Bile Acids.
Kilic T; Koromyslova A; Hansman GS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355683
[TBL] [Abstract][Full Text] [Related]
37. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
[TBL] [Abstract][Full Text] [Related]
38. Human Noroviruses Attach to Intestinal Tissues of a Broad Range of Animal Species.
Villabruna N; Schapendonk CME; Aron GI; Koopmans MPG; de Graaf M
J Virol; 2021 Jan; 95(3):. PubMed ID: 33115870
[TBL] [Abstract][Full Text] [Related]
39. Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016-2017 GII.2 Strains.
Mallory ML; Lindesmith LC; Brewer-Jensen PD; Graham RL; Baric RS
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899556
[TBL] [Abstract][Full Text] [Related]
40. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
Debbink K; Donaldson EF; Lindesmith LC; Baric RS
J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
